30 August 2022>: Original Paper
Clinical Validation of a Novel Scoring System Based on Donor and Recipient Risk Factors for Predicting Outcomes in Liver Transplantation
Lucas Souto Nacif ABCDEF* , Daniel Reis Waisberg CDE , Leonardo Yuri Zanini BCDEF , Rafael Soares Pinheiro ACD , Vinicius Rocha-Santos ACD , Rubens Arantes Macedo BD , Liliana Ducatti BD , Luciana Haddad BD , Rodrigo Bronze de Martino ACDE , Flávio Galvão AD , Wellington Andraus ACD , Luiz Carneiro-D’Albuquerque ADDOI: 10.12659/AOT.936271
Ann Transplant 2022; 27:e936271
Table 4 COX regression analysis (validation group – 70% bank randomly selected).
Coefficient | Risk | SD | IC 95% | Wald teste | p-value | |
---|---|---|---|---|---|---|
Retransplant | −17 | 1.60 | 0.29 | 3.6e-08 (0-Inf) | 0 | 0.99 |
Fulminant hepatitis | 0.66 | 0.20 | 0.23 | 1.90 (1.30–2.90) | 11 | |
Large surgery/biliary tree surgery | 0.45 | 0.21 | 0.21 | 1.60 (1.10–2.40) | 4.9 | 0.03 |
MELD (24–29) | 0.26 | 1.30 | 0.77 | 1.30 (0.70–2.23) | 25.6 | 0.34 |
MELD (29–35) | 0.51 | 1.66 | 0.60 | 1.66 (1.12–2.46) | 25.6 | 0.01 |
MELD (>35) | 0.90 | 2.46 | 0.41 | 2.46 (1.72–3.54 | 25.6 | |
Creatinine before transplant >1.5 mg/dL | 0.77 | 0.15 | 0.46 | 2.20 (1.60–2.90) | 26 | |
SD – standard deviation; IC – confidence index; MELD – model of end stage liver disease. Log-rank demonstrated p |